Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) fell 4.7% during trading on Wednesday after an insider sold shares in the company. The company traded as low as $70.04 and last traded at $70.24. 1,996,026 shares changed hands during mid-day trading, a decline of 9% from the average session volume of 2,193,090 shares. The stock […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) shares traded down 4.7% on Wednesday after an insider sold shares in the company. The stock traded as low as $70.04 and last traded at $70.24. 1,996,026 shares were traded during trading, a decline of 9% from the average session volume of 2,193,090 shares. The stock had […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $70.00, for a total transaction of $140,000.00. Following the sale, the executive vice president now directly owns 73,787 shares in the […]
Perfromance Wealth Partners LLC reduced its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 10.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,737 shares of the medical research company’s stock after selling 565 shares during the period. […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]